Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.

Masato YonedaTakuma YamamotoYasushi HondaKento ImajoYuji OgawaTakaomi KessokuTakashi KobayashiAsako NogamiTakuma HigurashiShingo KatoKunihiro HosonoSatoru SaitoHirokazu Takahashi

Published in: Journal of gastroenterology (2021)

Results indicated that incident rate of CVD increased with NAFLD/MAFLD; the complication rate of DM and hypertriglyceridemia among NAFLD/MAFLD patients is high and may affect the development of CVD.

Keyphrases

cardiovascular disease
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
health insurance
oxidative stress
emergency department
fatty acid
metabolic syndrome
insulin resistance
adverse drug